SightfileU.S. market data from official filings

RAPPORT THERAPEUTICS INC (RAPP)

Name: RAPPORT THERAPEUTICS INC (RAPP) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0002012593 · EDGAR filings · Updated 2026-07-15

RAPPORT THERAPEUTICS INC (RAPP) has reported institutional ownership of 109.8%, with 147 institutional managers holding positions valued at $1.64B per the latest 13F reporting period.

Institutional ownership

109.8%

Institutional managers

147

Reported 13F value

$1.64B

Insider activity

60 trans.

−$5.03M net selling

Latest updates

2026-07-15 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-07-01 — Insider transaction reported (Form 4)
2026-06-30 — Notice of proposed sale filed (Form 144)
2026-06-29 — Notice of proposed sale filed (Form 144)
2026-06-10 — Insider transaction reported (Form 4)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, RAPPORT THERAPEUTICS INC has 147 institutional holders and institutional ownership of 109.8%.

Insider activity

Insiders reported 60 transactions (4 buys, 51 sells) across 7 reporting insiders, with a net reported value of −$5.03M.

Related companies

PHARVARIS N V (PHVS) · AXOGEN INC (AXGN) · NATIONAL HEALTHCARE CORP (NHC) · VERADERMICS INC (MANE) · ARTIVION INC (AORT) · TREVI THERAPEUTICS INC (TRVI)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-15.